文献速递外周血管介入DSACT

第二代一体式单分支覆膜支架用于B型主动脉夹层胸主动脉腔内修复

Second-generation unibody single-branched stent-graft for thoracic endovascular aortic repair of type B aortic dissection.
PubMed 文献 · Eur Radiol · 2025-10-17

Cratos分支覆膜支架用于B型主动脉夹层TEVAR安全可行,更新后的装置释放简便、安全且准确。

要点

  • Cratos一体式单分支支架可同时完成B型夹层TEVAR与左锁骨下动脉血运重建。
  • 12个月分支段通畅率95.06%,支架覆盖段完全血栓化率92.59%(75/81)。
  • 术后30天死亡、卒中和脊髓缺血发生率均为1.1%,随访中2例(2.2%)非主动脉相关死亡。

核心结论

  • Cratos分支覆膜支架用于B型主动脉夹层TEVAR安全可行,更新后的装置释放简便、安全且准确。

研究设计与样本

  • 前瞻性、多中心研究,中国12中心连续纳入89例B型主动脉夹层患者,均使用Cratos分支覆膜支架行TEVAR,结果采用描述性统计,生存、免于再干预及分支通畅率用Kaplan-Meier估计。

诊断标准与关键数值

  • 30天死亡率1.1%(1例死于呼吸衰竭),卒中率1.1%,脊髓缺血率1.1%。
  • 中位随访369天,随访期间死亡2例(2.2%),均非主动脉相关。
  • 12个月分支段通畅率95.06%,支架覆盖段完全血栓化率92.59%(75/81)。

临床应用与阅片要点

  • Cratos支架可一期微创完成TEVAR并重建左锁骨下动脉,满足安全覆盖与血运重建需求。
  • 术后需关注内漏,原文报告2例内漏自行消退,但合并RTAD及Ia型内漏者未消退。
  • 1例因逆性A型主动脉夹层(RTAD)接受再干预。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the safety and feasibility of thoracic endovascular repair (TEVAR) of type B aortic dissection (TBAD) with Cratos branched stent-graft.

MATERIALS AND METHODS: A prospective, multicenter study consisting of consecutive TBAD patients across 12 centers in China who were treated with the Cratos branched stent-graft was conducted. Outcomes were reported using descriptive statistics. Overall survival, freedom from reintervention, and branch artery patency were estimated using Kaplan-Meier estimates.

RESULTS: The first enrollment started from January 2022 and ended in July 2023, with a total of 89 patients finally enrolled. All patients were diagnosed with TBAD and underwent TEVAR using the Cratos branched stent-graft. Technical success was achieved in all patients. One patient (1.1%) died of respiratory failure within the first 30 days after the operation. The rate was 1.1% for both stroke and spinal cord ischemia. The median follow-up was 369 days. Two patients (2.2%) died during follow-up, and neither death was related to the aorta. One patient had reintervention because of retrograde type A aortic dissection (RTAD). Two cases of endoleak resolved spontaneously but the one with RTAD and type Ia endoleak. Eighty-one patients completed a 12-month computed tomography angiography. The patency rate for the branch section was 95.06%. At the segment covered by the stent-graft, the complete thrombosis rate was 92.59% (75/81) at 12 months.

CONCLUSIONS: Cratos branched stent-graft was a safe and feasible device for TEVAR of TBAD. The updated device exhibited easy, safe, and accurate deployment. (Chinese Clinical Trial Register identifier: ChiCTR2200064412: ChiCTR2200064412).

KEY POINTS: Question How can thoracic endovascular aortic repair (TEVAR) for type B aortic dissection (TBAD) safely provide sufficient proximal landing while maintaining left subclavian artery perfusion? Findings The Cratos unibody single-branched stent-graft achieved high technical success, low complication rates, and excellent branch patency in treating TBAD while revascularizing the left subclavian artery. Clinical relevance The Cratos stent-graft enables one-stage, minimally invasive TEVAR for TBAD, addressing the need for safe left subclavian artery coverage and revascularization, thereby improving sealing, reducing complications, and enhancing clinical outcomes.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Li X, Liu X, Wang D, et al. Second-generation unibody single-branched stent-graft for thoracic endovascular aortic repair of type B aortic dissection. Eur Radiol. 2025. PMID: 41107493. doi:10.1007/s00330-025-12009-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。